These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

350 related items for PubMed ID: 23423907

  • 1. Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes.
    Horowitz M, Rayner CK, Jones KL.
    Adv Ther; 2013 Feb; 30(2):81-101. PubMed ID: 23423907
    [Abstract] [Full Text] [Related]

  • 2. Lixisenatide, a novel GLP-1 receptor agonist: efficacy, safety and clinical implications for type 2 diabetes mellitus.
    Bolli GB, Owens DR.
    Diabetes Obes Metab; 2014 Jul; 16(7):588-601. PubMed ID: 24373190
    [Abstract] [Full Text] [Related]

  • 3. The design and discovery of lixisenatide for the treatment of type 2 diabetes mellitus.
    Christensen M, Miossec P, Larsen BD, Werner U, Knop FK.
    Expert Opin Drug Discov; 2014 Oct; 9(10):1223-51. PubMed ID: 25119443
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of GLP-1 receptor agonists on components of dysglycaemia in individuals with type 2 diabetes mellitus.
    Owens DR, Monnier L, Bolli GB.
    Diabetes Metab; 2013 Dec; 39(6):485-96. PubMed ID: 24156868
    [Abstract] [Full Text] [Related]

  • 5. Pronounced reduction of postprandial glucagon by lixisenatide: a meta-analysis of randomized clinical trials.
    Ahrén B, Gautier JF, Berria R, Stager W, Aronson R, Bailey CJ.
    Diabetes Obes Metab; 2014 Sep; 16(9):861-8. PubMed ID: 24641271
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus.
    Forst T, Pfützner A.
    Expert Opin Pharmacother; 2013 Nov; 14(16):2281-96. PubMed ID: 24087882
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of glucagon-like peptide-1 receptor agonists on secretions of insulin and glucagon and gastric emptying in Japanese individuals with type 2 diabetes: A prospective, observational study.
    Kuwata H, Yabe D, Murotani K, Fujiwara Y, Haraguchi T, Kubota S, Kubota-Okamoto S, Usui R, Ishitobi M, Yamazaki Y, Hamamoto Y, Kurose T, Seino Y, Yamada Y, Seino Y.
    J Diabetes Investig; 2021 Dec; 12(12):2162-2171. PubMed ID: 34022121
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lixisenatide as add-on to oral anti-diabetic therapy: an effective treatment for glycaemic control with body weight benefits in type 2 diabetes.
    Raccah D, Gourdy P, Sagnard L, Ceriello A.
    Diabetes Metab Res Rev; 2014 Nov; 30(8):742-8. PubMed ID: 24687427
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Beneficial effects of once-daily lixisenatide on overall and postprandial glycemic levels without significant excess of hypoglycemia in type 2 diabetes inadequately controlled on a sulfonylurea with or without metformin (GetGoal-S).
    Rosenstock J, Hanefeld M, Shamanna P, Min KW, Boka G, Miossec P, Zhou T, Muehlen-Bartmer I, Ratner RE.
    J Diabetes Complications; 2014 Nov; 28(3):386-92. PubMed ID: 24650952
    [Abstract] [Full Text] [Related]

  • 19. A systematic review and meta-analysis of the efficacy of lixisenatide in the treatment of patients with type 2 diabetes.
    Schmidt LJ, Habacher W, Augustin T, Krahulec E, Semlitsch T.
    Diabetes Obes Metab; 2014 Sep; 16(9):769-79. PubMed ID: 24476092
    [Abstract] [Full Text] [Related]

  • 20. Effects of lixisenatide once daily on gastric emptying in type 2 diabetes--relationship to postprandial glycemia.
    Lorenz M, Pfeiffer C, Steinsträsser A, Becker RH, Rütten H, Ruus P, Horowitz M.
    Regul Pept; 2013 Aug 10; 185():1-8. PubMed ID: 23665027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.